BiochemistrybioRxiv
Exploring novel fluorine rich fuberidazole derivatives as hypoxic cancer inhibitors: design, synthesis, pharmacokinetics, molecular docking and DFT evaluations
This study synthesizes and evaluates sixteen fuberidazole derivatives as hypoxic cancer inhibitors, identifying eight with good cytotoxic properties and analyzing their molecular interactions and pharmacokinetics.
DOI 10.1371/journal.pone.0262790